Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone).
D000818:Animals; D001952:Bridged-Ring Compounds; D003916:Dextromoramide / Q000494:pharmacology; D004357:Drug Synergism; D004558:Electric Stimulation; D005663:Furans; D006168:Guinea Pigs; D003932:Heroin / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007659:Ketones; D007977:Levallorphan / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009269:Nalorphine / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010616:Phenanthrenes; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011955:Receptors, Drug; D013618:Tachyphylaxis
D001952:Bridged-Ring Compounds; D005663:Furans; D007659:Ketones; D009292:Narcotic Antagonists; D010616:Phenanthrenes; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D007977:Levallorphan; D003932:Heroin; D009020:Morphine; D003916:Dextromoramide; D011433:Propranolol; D009269:Nalorphine